Viewing Study NCT05859334


Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2025-12-27 @ 11:10 PM
Study NCT ID: NCT05859334
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2023-05-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module